Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial

por Sakuma, Masashi, Toyoda, Shigeru, Arikawa, Takuo, Koyabu, Yota, Kato, Toru, Adachi, Taichi, Suwa, Hideaki, Narita, Jun-ichi, Anraku, Koetsu, Ishimura, Kimihiko, Yamauchi, Fumitake, Sato, Yasunori, Inoue, Teruo
Publicado 2022